ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR DOSING AND EXPECTED ACUITY OUTCOME AT 1 YEAR. Spaide RF. Retina 2021;41:1153-1163.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Spaide RF. ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR DOSING AND EXPECTED ACUITY OUTCOME AT 1 YEAR. Retina 2021;41:1153-1163.
PMID: 33464022